Sturm, Ruger & Company (RGR) Q4 2025 earnings summary
Event summary combining transcript, slides, and related documents.
Q4 2025 earnings summary
2 Mar, 2026Executive summary
Navigated a challenging year for the firearms industry, marked by inflation, constrained consumer spending, and normalized demand after prior elevated years.
Leadership transition completed, with a new CEO and a refreshed board focused on operational excellence and long-term strategy.
Fourth quarter net sales reached $151.1 million, up 3.6% year-over-year, with full-year net sales at $546.1 million, a 1.9% increase from 2024.
Launched 65 new models in Q4, including three new platforms, driving strong consumer demand and outperforming the broader market.
Financial highlights
Q4 net sales rose 3.6% year-over-year to $151.1 million; full-year net sales up 1.9% to $546.1 million.
Q4 diluted EPS was $0.21 ($0.26 adjusted); full-year net loss of $0.27 per share ($0.84 adjusted).
Gross profit for 2025 was $81.2 million, down from $114.4 million in 2024.
Cash from operations totaled $54.3 million in 2025; ended year with $92.5 million in cash and no debt.
Returned $36.2 million to shareholders via $10.1 million in dividends and $26 million in share repurchases.
Outlook and guidance
Expecting a flat-to-down industry environment in 2026; focus remains on sustaining top-line performance and protecting market share.
Plans to expand operating margins through disciplined cost alignment and structural efficiency.
Continued emphasis on innovation, with multiple new firearm platforms and accessory expansions planned.
Management remains focused on improving profitability, aligning manufacturing with demand, and investing in future growth.
Latest events from Sturm, Ruger & Company
- Board refresh and Ruger 2030 strategy drive strong returns and disciplined growth.RGR
Proxy filing24 Mar 2026 - Ruger’s board rebuffed Beretta’s control efforts, reinforcing governance and shareholder protections.RGR
Proxy Filing10 Mar 2026 - Beretta’s bid for board control prompts defensive measures and governance refreshment.RGR
Proxy Filing9 Mar 2026 - Board composition refreshed with new independent directors amid shareholder proposals.RGR
Proxy Filing3 Mar 2026 - Q2 sales and profit declined, but new products and efficiency gains support future growth.RGR
Q2 20242 Feb 2026 - Q3 2024 sales rose 1.2% to $122.3M, but EPS and net income declined on margin pressure.RGR
Q3 202417 Jan 2026 - Net income up 9.7% on flat sales, strong liquidity, and rising CapEx for innovation.RGR
Q1 202524 Dec 2025 - Q4 sales and earnings rebounded on new product strength and market share gains.RGR
Q4 202423 Dec 2025 - Board recommends director elections, auditor ratification, and executive pay policies for 2025.RGR
Proxy Filing1 Dec 2025